Cargando…
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer
The mechanisms underlying the role of CXCL5 in tumor angiogenesis have not been fully defined. Here, we examined the effect of CXCL5 on tumor angiogenesis in colorectal cancer (CRC). Immunohistochemistry was used to monitor the expression of CXCL5 and CD31 in CRC patients’ tissues. HUVEC cell lines...
Autores principales: | Chen, Chun, Xu, Zhuo-Qing, Zong, Ya-Ping, Ou, Bao-Chi, Shen, Xiao-Hui, Feng, Hao, Zheng, Min-Hua, Zhao, Jing-Kun, Lu, Ai-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385313/ https://www.ncbi.nlm.nih.gov/pubmed/30792394 http://dx.doi.org/10.1038/s41419-019-1431-6 |
Ejemplares similares
-
FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization
por: Feng, Wen-Qing, et al.
Publicado: (2023) -
FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
por: Wu, Qiong, et al.
Publicado: (2020) -
FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma
por: Li, Dan, et al.
Publicado: (2013) -
Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
por: Zong, Yaping, et al.
Publicado: (2022) -
CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
por: Zhuo, Changhua, et al.
Publicado: (2022)